Prevalence and outcomes of neonates with severe COVID-19: An observational study at Children’s Hospital 1 in Ho Chi Minh City, Vietnam

Abstract

Objective: To evaluate the impact of the severe COVID-19 pandemic on neonates and develop strategies to improve their outcomes.

Methods: We conducted an observational cross-sectional study at Children's Hospital 1 (CH1) from July 25, 2021, to May 31, 2022. All neonates who had fever or respiratory symptoms or were born from mothers with COVID-19 and had a positive RT-PCR SARS-CoV-2 result would be included. We classified neonates with COVID-19 into 2 groups: mild/moderate and severe for analysis. Differences between groups were analyzed using Fisher's exact test/Chi-square test for categorical variables and Student's t-test/Wilcoxon Rank Sum test for continuous variables.

Results: This study included 88 newborns who had positive RT-PCR SARS-CoV-2 results. The severity COVID-19 rate among neonatal cases was found to be 13.6% (12/88), with a corresponding mortality rate of 1.1% (1/88). All severe cases showed lung abnormalities as evident on chest X-ray images. In addition to respiratory symptoms, a higher incidence of gastrointestinal manifestations, such as vomiting and diarrhea, was observed in the severe group, indicating a compelling association. The administration of anticoagulant and anti-inflammatory drugs in the study group resulted in a satisfactory outcome with no significant complications.

Conclusions: The COVID-19 pandemic has had a substantial impact on the well-being of neonates. The management of COVID-19 in this population presents significant challenges.

Keywords

COVID-19 / Neonate / Anti-inflammatory / Anticoagulant

References

[1] Duke T, English M, Carai S, Qazi S. Paediatric care in the time of COVID-19 in countries with under-resourced healthcare systems. Arch Dis Child 2020; 105(7): 616-617.

[2] Eibschutz LS, Bruckhaus AA, Bennett A, Duncan D, Sackett C, Dave K, et al. Global impact of COVID-19 on healthcare systems. In: Ali Gholamrezanezhad, Michael P. Dube (eds.) Coronavirus disease 2019 (COVID-19): A clinical guide. New Jersey: Wiley Online Library; 2022, p. 615-650.

[3] Kitano T, Kitano M, Krueger C, Jamal H, Al Rawahi H, Lee-Krueger R, et al. The differential impact of pediatric COVID-19 between high-income countries and low and middle-income countries: A systematic review of fatality and ICU admission in children worldwide. PloS One 2021; 16(1): e0246326.

[4] World Health Organisation. WHO coronavirus (COVID-19) dashboard. [Online]. Available from: https://covid19.who.int/. [Accessed on 30 October 2023].

[5] Ministry of Health of Vietnam. CỔNG THÔNG TIN CỦA BỘ Y TẾ VỀ ĐẠI DỊCH COVID-19. [Online]. Available from: https://covid19.gov.vn/. [Accessed on 29 June 2022].

[6] Devin J, Marano R, Mikhael M, Feaster W, Sanger T, Ehwerhemuepha L. Epidemiology of neonatal COVID-19 in the United States. Pediatrics 2022; 150(4): e2022056297.

[7] Gale C, Quigley MA, Placzek A, Knight M, Ladhani S, Draper ES, et al. Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: A prospective national cohort study using active surveillance. Lancet Child Adolesc Health 2021; 5(2): 113-121.

[8] Nguyen PNT, Thuc TT, Hung NT, Thinh LQ, Minh NNQ, Duy DQ, et al. Risk factors for disease severity and mortality of children with Covid-19: A study at a Vietnamese Children's hospital. J Infect & Chemother 2022; 28(10): 1380-1386.

[9] Stokes EK, Zambrano LD, Anderson KN, Marder EP, Raz KM, El Burai Felix S, et al. Coronavirus Disease 2019 case surveillance-United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep 2020; 69(24): 759-765.

[10] Galderisi A, Lista G, Cavigioli F, Trevisanuto D. Clinical features of neonatal COVID-19. Semin Fetal Neonatal Med 2023; 28(2): 101430.

[11] Irfan O, Muttalib F, Tang K, Jiang L, Lassi ZS, Bhutta Z. Clinical characteristics, treatment and outcomes of paediatric COVID-19: A systematic review and meta-analysis. Arch Dis Child 2021; 106(5): 440-448.

[12] Poline J, Gaschignard J, Leblanc C, Madhi F, Foucaud E, Nattes E, et al. Systematic severe acute respiratory syndrome coronavirus 2 screening at hospital admission in children: A French prospective multicenter study. Clin Infect Dis 2021; 72(12): 2215-2217.

[13] de Souza TH, Nadal JA, Nogueira RJN, Pereira RM, Brandao MB. Clinical manifestations of children with COVID-19: A systematic review. Pediatr Pulmonol 2020; 55(8): 1892-1899.

[14] Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 infection in children. N Engl J Med 2020; 382(17): 1663-1665.

[15] Singh P, Attri K, Mahto D, Kumar V, Kapoor D, Seth A, et al. Clinical profile of COVID-19 illness in children-experience from a tertiary care hospital. Indian J Pediatr 2022; 89(1): 45-51.

[16] Tsankov BK, Allaire JM, Irvine MA, Lopez AA, Sauvé LJ, Vallance BA, et al. Severe COVID-19 infection and pediatric comorbidities: A systematic review and meta-analysis. Int J Infect Dis 2021; 103: 246-256.

[17] Ryan L, Plötz FB, van den Hoogen A, Latour JM, Degtyareva M, Keuning M, et al. Neonates and COVID-19: State of the art: Neonatal sepsis series. Pediatr Res 2022; 91(2): 432-439.

[18] Cyranoski D. Why children avoid the worst coronavirus complications might lie in their arteries. Nature 2020; 582(7812): 324-325.

[19] Kotlyar AM, Grechukhina O, Chen A, Popkhadze S, Grimshaw A, Tal O, et al. Vertical transmission of coronavirus disease 2019: A systematic review and meta-analysis. Am J Obstet Gynecol 2021; 224(1): 35-53.e3.

[20] Babaei R, Bokharaei-Salim F, Khanaliha K, Kiani SJ, Marjani A, Garshasbi S, et al. Prevalence of SARS-CoV-2 infection in neonates born to mothers or relatives with COVID-19. BMC Infect Dis 2022; 22(1): 730.

[21] Di Toro F, Gjoka M, Di Lorenzo G, De Santo D, De Seta F, Maso G, et al. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Microbiol Infect 2021; 27(1): 36-46.

[22] Harwood R, Yan H, Talawila Da Camara N, Smith C, Ward J, Tudur-Smith C, et al. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis. eClinicalMedicine 2022; 44: 101287.

[23] De Rose DU, Piersigilli F, Ronchetti MP, Santisi A, Bersani I, Dotta A, et al. Novel coronavirus disease (COVID-19) in newborns and infants: What we know so far. Ital J Pediatr 2020; 46(1): 56.

[24] Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, et al. 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19. Ann Rheum Dis 2022; 81(1): 34-40.

[25] Goldenberg NA, Sochet A, Albisetti M, Biss T, Bonduel M, Jaffray J, et al. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness. J Thromb Haemost 2020; 18(11): 3099-3105.

[26] Becker RC. COVID-19 update: COVID-19-associated coagulopathy. J Thromb Thrombolysis 2020; 50(1): 54-67.